TY - JOUR
T1 - Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC2-NIN-CP)
AU - Baptista, Abrahao Fontes
AU - Fernandes, Ana Mercia B. L.
AU - Sa, Katia Nunes
AU - Okano, Alexandre Hideki
AU - Brunoni, Andre Russowsky
AU - Lara-Solares, Argelia
AU - Jreige Iskandar, Aziza
AU - Guerrero, Carlos
AU - Amescua-Garcia, Cesar
AU - Kraychete, Durval Campos
AU - Caparelli-Daquer, Egas
AU - Atencio, Elias
AU - Piedimonte, Fabian
AU - Colimon, Frantz
AU - Hazime, Fuad Ahmed
AU - Garcia, Joao Batista S.
AU - Hernandez-Castro, John Jairo
AU - Cantisani, Jose Alberto Flores
AU - Karina do Monte-Silva, Katia
AU - Lemos Correia, Luis Claudio
AU - Gallegos, Manuel Sempertegui
AU - Marcolin, Marco Antonio
AU - Ricco, Maria Antonieta
AU - Cook, Maria Berenguel
AU - Bonilla, Patricia
AU - Schestatsky, Pedro
AU - Galhardoni, Ricardo
AU - Silva, Valquiria
AU - Delgado Barrera, William
AU - Caumo, Wolnei
AU - Bouhassira, Didier
AU - Chipchase, Lucy S.
AU - Lefaucheur, Jean-Pascal
AU - Teixeira, Manoel Jacobsen
AU - Andrade, Daniel Ciampi de
PY - 2019
Y1 - 2019
N2 - Introduction: Chronic pain (CP) is highly prevalent and generally undertreated health condition. Noninvasive brain stimulation may contribute to decrease pain intensity and influence other aspects related to CP. Objective: To provide consensus-based recommendations for the use of noninvasive brain stimulation in clinical practice. Methods: Systematic review of the literature searching for randomized clinical trials followed by consensus panel. Recommendations also involved a cost-estimation study. Results: The systematic review wielded 24 transcranial direct current stimulation (tDCS) and 22 repetitive transcranial magnetic stimulation (rTMS) studies. The following recommendations were provided: (1) Level A for anodal tDCS over the primary motor cortex (M1) in fibromyalgia, and level B for peripheral neuropathic pain, abdominal pain, and migraine; bifrontal (F3/F4) tDCS and M1 high-definition (HD)-tDCS for fibromyalgia; Oz/Cz tDCS for migraine and for secondary benefits such as improvement in quality of life, decrease in anxiety, and increase in pressure pain threshold; (2) level A recommendation for high-frequency (HF) rTMS over M1 for fibromyalgia and neuropathic pain, and level B for myofascial or musculoskeletal pain, complex regional pain syndrome, and migraine; (3) level A recommendation against the use of anodal M1 tDCS for low back pain; and (4) level B recommendation against the use of HF rTMS over the left dorsolateral prefrontal cortex in the control of pain. Conclusion: Transcranial DCS and rTMS are recommended techniques to be used in the control of CP conditions, with low to moderate analgesic effects, and no severe adverse events. These recommendations are based on a systematic review of the literature and a consensus made by experts in the field. Readers should use it as part of the resources available to decision-making.
AB - Introduction: Chronic pain (CP) is highly prevalent and generally undertreated health condition. Noninvasive brain stimulation may contribute to decrease pain intensity and influence other aspects related to CP. Objective: To provide consensus-based recommendations for the use of noninvasive brain stimulation in clinical practice. Methods: Systematic review of the literature searching for randomized clinical trials followed by consensus panel. Recommendations also involved a cost-estimation study. Results: The systematic review wielded 24 transcranial direct current stimulation (tDCS) and 22 repetitive transcranial magnetic stimulation (rTMS) studies. The following recommendations were provided: (1) Level A for anodal tDCS over the primary motor cortex (M1) in fibromyalgia, and level B for peripheral neuropathic pain, abdominal pain, and migraine; bifrontal (F3/F4) tDCS and M1 high-definition (HD)-tDCS for fibromyalgia; Oz/Cz tDCS for migraine and for secondary benefits such as improvement in quality of life, decrease in anxiety, and increase in pressure pain threshold; (2) level A recommendation for high-frequency (HF) rTMS over M1 for fibromyalgia and neuropathic pain, and level B for myofascial or musculoskeletal pain, complex regional pain syndrome, and migraine; (3) level A recommendation against the use of anodal M1 tDCS for low back pain; and (4) level B recommendation against the use of HF rTMS over the left dorsolateral prefrontal cortex in the control of pain. Conclusion: Transcranial DCS and rTMS are recommended techniques to be used in the control of CP conditions, with low to moderate analgesic effects, and no severe adverse events. These recommendations are based on a systematic review of the literature and a consensus made by experts in the field. Readers should use it as part of the resources available to decision-making.
KW - chronic pain
KW - magnetic brain stimulation
KW - nociceptive pain
KW - treatment
UR - http://handle.westernsydney.edu.au:8081/1959.7/uws:49414
UR - https://journals.lww.com/painrpts/Abstract/latest/Latin_American_and_Caribbean_consensus_on.99887.aspx
U2 - 10.1097/PR9.0000000000000692
DO - 10.1097/PR9.0000000000000692
M3 - Article
SN - 2471-2531
VL - 4
JO - Pain Reports
JF - Pain Reports
IS - 1
M1 - e692
ER -